0000950138-24-000011.txt : 20240815 0000950138-24-000011.hdr.sgml : 20240815 20240815172643 ACCESSION NUMBER: 0000950138-24-000011 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240815 DATE AS OF CHANGE: 20240815 EFFECTIVENESS DATE: 20240815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stereotaxis, Inc. CENTRAL INDEX KEY: 0001289340 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 943120386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-521697 FILM NUMBER: 241213492 BUSINESS ADDRESS: STREET 1: 710 N TUCKER BLVD STREET 2: STE 110 CITY: ST.LOUIS STATE: MO ZIP: 63101 BUSINESS PHONE: 314-678-6100 MAIL ADDRESS: STREET 1: 710 N TUCKER BLVD STREET 2: STE 110 CITY: ST.LOUIS STATE: MO ZIP: 63101 D 1 primary_doc.xml X0708 D LIVE 0001289340 Stereotaxis, Inc. 710 N TUCKER BLVD ST.LOUIS MO MISSOURI 63101 314-678-6100 DELAWARE None None Corporation true David L. Fischel c/o Stereotaxis, Inc. 710 North Tucker Boulevard St. Louis MO MISSOURI 63101 Executive Officer Director Kimberly R. Peery c/o Stereotaxis, Inc. 710 North Tucker Boulevard St. Louis MO MISSOURI 63101 Executive Officer Director David W. Benfer c/o Stereotaxis, Inc. 710 North Tucker Boulevard St. Louis MO MISSOURI 63101 Director Myriam Curet c/o Stereotaxis, Inc. 710 North Tucker Boulevard St. Louis MO MISSOURI 63101 Director Nathan Fischel c/o Stereotaxis, Inc. 710 North Tucker Boulevard St. Louis MO MISSOURI 63101 Director Ross B. Levin c/o Stereotaxis, Inc. 710 North Tucker Boulevard St. Louis MO MISSOURI 63101 Director Arun S. Menawat c/o Stereotaxis, Inc. 710 North Tucker Boulevard St. Louis MO MISSOURI 63101 Director Nachum Shamir c/o Stereotaxis, Inc. 710 North Tucker Boulevard St. Louis MO MISSOURI 63101 Director Other Technology Decline to Disclose 06b false 2024-07-31 true true true 0 Indefinite 3000000 Indefinite Issuance of additional shares is contingent upon achievement of certain product revenue and regulatory approval milestones, currently estimated to be $9,309,800. false 1 0 0 0 false Stereotaxis, Inc. /s/ Kimberly R. Peery Kimberly R. Peery Chief Financial Officer 2024-08-15